Single-Cell Transcriptome Analysis Reveals Mesenchymal Stem Cells In

Total Page:16

File Type:pdf, Size:1020Kb

Single-Cell Transcriptome Analysis Reveals Mesenchymal Stem Cells In bioRxiv preprint doi: https://doi.org/10.1101/2021.09.02.458742; this version posted September 3, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 1 Single-cell transcriptome analysis reveals mesenchymal stem cells 2 in cavernous hemangioma 3 Fulong Ji1$, Yong Liu2$, Jinsong Shi3$, Chunxiang Liu1, Siqi Fu1 4 Heng Wang1, Bingbing Ren1, Dong Mi4, Shan Gao2*, Daqing Sun1* 5 1 Department of Paediatric Surgery, Tianjin Medical University General Hospital, Tianjin 300052, P.R. China. 6 China. 7 2 College of Life Sciences, Nankai University, Tianjin, Tianjin 300071, P.R. China; 8 3 National Clinical Research Center of Kidney Disease, Jinling Hospital, Nanjing University School of 9 Medicine, Nanjing, Jiangsu 210016, P.R. China; 10 4 School of Mathematical Sciences, Nankai University, Tianjin, Tianjin 300071, P.R. China; 11 12 13 $ These authors contributed equally to this paper. 14 * Corresponding authors. 15 SG:[email protected] 16 DS:[email protected] 17 bioRxiv preprint doi: https://doi.org/10.1101/2021.09.02.458742; this version posted September 3, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 18 Abstract 19 A cavernous hemangioma, well-known as vascular malformation, is present at birth, grows 20 proportionately with the child, and does not undergo regression. Although a cavernous hemangioma 21 has well-defined histopathological characteristics, its origin and formation remain unknown. In the present 22 study, we characterized the cellular heterogeneity of cavernous hemangioma using single-cell RNA 23 sequencing (scRNA-seq). The main contribution of this study is the discovery of mesenchymal stem cells 24 (MSCs) that cause tumour formation in cavernous hemangioma and we propose that these MSCs may be 25 abnormally differentiated or incompletely differentiated from epiblast stem cells. 26 Other new findings include the responsive ACKR1 positive endothelial cell (ACKR1+EC) and BTNL9 27 positive endothelial cell (BTNL9+EC) and the BTNL9-caused checkpoint blockade enhanced by the 28 CXCL12-CXCR4 signalling. The activated CD8+T and NK cells may highly express CCL5 for their 29 infiltration in cavernous hemangiomas, independent on the tumor cell-derived CCL5-IFNG-CXCL9 pathway. 30 The highly co-expression of CXCR4 and GZMB suggested that plasmacytoid dendritic cells (pDCs) function 31 for anti-tumour as CD8+T cells in cavernous hemangiomas. The oxidised low-density lipoprotein (oxLDL) 32 in the TME of cavernous hemangiomas may play an important role as a signalling molecular in the immune 33 responses. Notably, we propose that oxLDL induces the oxLDL-OLR1-NLRP3 pathway by over-expression 34 of OLR1 in M1-like macrophages, whereas oxLDL induces the oxLDL-SRs-C1q (SRs are genes encoding 35 scavenger receptors of oxLDL except OLR1) pathway by over-expression of other scavenger receptors in 36 M2-like macrophages. 37 The present study revealed the origin of cavernous hemangiomas and discovered marker genes, cell 38 types and molecular mechanisms associated with the origin, formation, progression, diagnosis or therapy of 39 cavernous hemangiomas. The information from the present study makes important contributions to the 40 understanding of cavernous hemangioma formation and progression and facilitates the development of gold 41 standard for molecular diagnosis and effective drugs for treatment. 42 Keyword: MSC; Vascular malformation; Vascular tumor; Stem cell; scRNA-seq 43 bioRxiv preprint doi: https://doi.org/10.1101/2021.09.02.458742; this version posted September 3, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 44 Introduction 45 Vascular tumours include hemangioma, hemangioendothelioma, angiosarcoma, and their epithelioid 46 variants [1]. According to the size of the affected vessels, hemangiomas are histologically classified as 47 capillary, cavernous, or mixed-type hemangiomas [2]. A capillary hemangioma (superficial, red, raised), 48 also called strawberry hemangioma, is a tumour of infancy that undergoes a phase of rapid growth and 49 expansion followed by a period of slow but steady regression during childhood. In contrast, a cavernous 50 hemangioma (deep dermal, blue hue), which is now classified as vascular malformation according to the 51 International Society for the Study of Vascular Anomalies (ISSVA) classification [3], is present at birth, 52 grows proportionately with the child, and does not undergo regression [4]. Major features used to 53 discriminate cavernous hemangiomas from capillary hemangiomas include the observation of “normal” 54 vascular endothelial cells in cavernous hemangiomas and the over-expression of vascular endothelial growth 55 factor A (VEGFA) and fibroblast growth factor receptor 1 (FGFR1) in capillary hemangiomas during the 56 proliferative stage [6]. Cavernous hemangiomas have been reported to arise at various sites, including the 57 skin and subcutaneous layers of the head and neck, face, extremities, liver, gastrointestinal tract, and even 58 the thymus [5]. The tumours are composed of dilated vascular spaces, with thinned smooth muscle walls 59 separated by a variable amount of fibroconnective tissue. 60 Three classes of cavernous hemangiomas hepatic cavernous hemangioma (HCH), retinal cavernous 61 hemangioma (RCH), and cerebral cavernous hemangioma (CCH), also known as cerebral cavernous 62 malformation (CCM), are comparatively well studied. HCH, the most common benign tumour of the liver, is 63 present in up to 7% of individuals that participate in autopsy studies. Histological examination of the lesions 64 revealed a network of vascular spaces lined by endothelial cells and separated by a thin fibrous stroma. 65 Large HCHs may be associated with thrombosis, scarring, and calcification [7]. RCH is composed of 66 clusters of saccular aneurysms filled with dark blood. Microscopic examination of the lesions revealed 67 multiple thin-walled interconnected vascular spaces lined by flat endothelial cells, with red cell necrosis and 68 partially organised intravascular thrombosis. Vascular spaces are bordered by thin, fibrous septa, with 69 occasional nerve fibers and glial cells. Although mutations in KRIT1 and CCM1 genes have been found in 70 patients with both RCH and CCH [8], the cause of RCH remains unknown. CCHs that occur in the central 71 nervous system, most often in the brain, can cause intracranial hemorrhage, seizures, neurological deficits, 72 and even death. Ultrastructural studies revealed abnormal or absent blood–brain barrier components, poorly 73 formed tight junctions with gaps between endothelial cells, lack of astrocytic foot processes, and few bioRxiv preprint doi: https://doi.org/10.1101/2021.09.02.458742; this version posted September 3, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. 74 pericytes in the lesions. CCH has sporadic and familial forms; familial CCHs often display multiple lesions 75 and autosomal dominant inheritance. According to the current theory, capillary hemangiomas originate from 76 neogenesis or revival of dormant embryonic angioblasts and arise through hormonally driven vessel growth 77 [4], while familial CCHs may be caused by loss-of-function mutations in three genes, KRIT1, CCM2, and 78 PDCD10 [9]. However, the origins of capillary and cavernous hemangiomas remain controversial and 79 unknown, respectively. 80 Although capillary hemangiomas are mainly treated via surgery, several drugs (e.g., propranolol and 81 glucocorticoids) have been developed to avoid the risks of intraoperative profuse bleeding, postoperative 82 recurrence, long-term scarring, and other complications. The treatment of cavernous hemangiomas is still 83 dependent on excision and venous embolization therapy [3]; however, inadequate excision causes recurrence 84 of cavernous hemangiomas [10]. To develop drugs or other new therapies, more basic research must be 85 conducted to understand cavernous hemangiomas at the molecular level. In the present study, we 86 characterised the cellular heterogeneity of cavernous hemangioma using single-cell RNA sequencing 87 (scRNA-seq) [11]. Through further analysis of the scRNA-seq data, we aimed to: (1) reveal the 88 comprehensive cellular composition and gene expression profile of a cavernous hemangioma at the 89 single-cell level, and (2) discover marker genes, cell types, and molecular mechanisms associated with the 90 origin, formation, progression, diagnosis, and therapy of cavernous hemangiomas. 91 92 Results 93 Single-cell RNA sequencing and basic analyses 94 The lesion was obtained as tumour tissue from a 6-year-old patient diagnosed with cavernous 95 hemangioma (Supplementary File 1). Using tissue in the center of the lesion, scRNA-seq libraries (10x 96 Genomics, USA) were constructed and sequenced to produce ~163 Gbp of raw data (Materials and 97
Recommended publications
  • Supplementary Information
    doi: 10.1038/nature08795 SUPPLEMENTARY INFORMATION Supplementary Discussion Population naming In some contexts, the indigenous hunter-gatherer and pastoralist peoples of southern Africa are referred to collectively as the Khoisan (Khoi-San) or more recently Khoesan (Khoe-San) people. This grouping is based on the unique linguistic use of click-consonants1. Many names, often country-specific, have been used by Bantu pastoralists and European settlers to describe the hunter-gatherers, including San, Saan, Sonqua, Soaqua, Souqua, Sanqua, Kwankhala, Basarwa, Batwa, Abathwa, Baroa, Bushmen, Bossiesmans, Bosjemans, or Bosquimanos. In addition, group-specific names such as !Kung and Khwe are often used for the broader population. The two most commonly used names, “San” and “Bushmen”, have both been associated with much controversy due to derogatory connotations2. “San” has become the more popular term used in Western literature, although “Bushmen” is arguably the more commonly recognized term within the communities. Since they have no collective name for themselves, the term Bushmen was selected for use in this paper as the term most familiar to the participants themselves. Regarding identification of individuals The five men identified in this study have all elected to have their identity made public knowledge. Thus we present two complete personal genomes (KB1 and ABT), a low-coverage personal genome (NB1), and personal exomes for all five men. On a scientific level, identification allows for current and future correlation of genetic data with demographic and medical histories. On a social level, identification allows for maximizing community benefit. For !Gubi, G/aq’o, D#kgao and !Aî, their name represents not only themselves, but importantly their extended family unit and a way of life severely under threat.
    [Show full text]
  • Transcription Factor Creb3l1 Regulates the Synthesis of Prohormone Convertase Enzyme PC1/3 in Endocrine Cells
    Greenwood, M., Paterson, A., Rahman, P. A., Gillard, B. T., Langley, S., Iwasaki, Y., Murphy, D., & Greenwood, M. P. (2020). Transcription factor Creb3l1 regulates the synthesis of prohormone convertase enzyme PC1/3 in endocrine cells. Journal of Neuroendocrinology, 32(4), [E12851]. https://doi.org/10.1111/jne.12851 Publisher's PDF, also known as Version of record License (if available): CC BY Link to published version (if available): 10.1111/jne.12851 Link to publication record in Explore Bristol Research PDF-document This is the final published version of the article (version of record). It first appeared online via Wiley at https://onlinelibrary.wiley.com/doi/full/10.1111/jne.12851 . Please refer to any applicable terms of use of the publisher. University of Bristol - Explore Bristol Research General rights This document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/red/research-policy/pure/user-guides/ebr-terms/ Received: 11 November 2019 | Revised: 31 March 2020 | Accepted: 31 March 2020 DOI: 10.1111/jne.12851 ORIGINAL ARTICLE Transcription factor Creb3l1 regulates the synthesis of prohormone convertase enzyme PC1/3 in endocrine cells Mingkwan Greenwood1 | Alex Paterson1 | Parveen Akhter Rahman1 | Benjamin Thomas Gillard1 | Sydney Langley1 | Yasumasa Iwasaki2 | David Murphy1 | Michael Paul Greenwood1 1Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, Abstract UK Transcription factor cAMP responsive element-binding protein 3 like 1 (Creb3l1) is a 2 Health Care Center, Kochi University, non-classical endoplasmic reticulum stress molecule that is emerging as an important Kochi, Japan component for cellular homeostasis, particularly within cell types with high peptide Correspondence secretory capabilities.
    [Show full text]
  • Analysis of Trans Esnps Infers Regulatory Network Architecture
    Analysis of trans eSNPs infers regulatory network architecture Anat Kreimer Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Graduate School of Arts and Sciences COLUMBIA UNIVERSITY 2014 © 2014 Anat Kreimer All rights reserved ABSTRACT Analysis of trans eSNPs infers regulatory network architecture Anat Kreimer eSNPs are genetic variants associated with transcript expression levels. The characteristics of such variants highlight their importance and present a unique opportunity for studying gene regulation. eSNPs affect most genes and their cell type specificity can shed light on different processes that are activated in each cell. They can identify functional variants by connecting SNPs that are implicated in disease to a molecular mechanism. Examining eSNPs that are associated with distal genes can provide insights regarding the inference of regulatory networks but also presents challenges due to the high statistical burden of multiple testing. Such association studies allow: simultaneous investigation of many gene expression phenotypes without assuming any prior knowledge and identification of unknown regulators of gene expression while uncovering directionality. This thesis will focus on such distal eSNPs to map regulatory interactions between different loci and expose the architecture of the regulatory network defined by such interactions. We develop novel computational approaches and apply them to genetics-genomics data in human. We go beyond pairwise interactions to define network motifs, including regulatory modules and bi-fan structures, showing them to be prevalent in real data and exposing distinct attributes of such arrangements. We project eSNP associations onto a protein-protein interaction network to expose topological properties of eSNPs and their targets and highlight different modes of distal regulation.
    [Show full text]
  • A Study of Chemotherapy Resistance in Acute Myeloid Leukemia
    A Study of Chemotherapy Resistance in Acute Myeloid Leukemia A DISSERTATION SUBMITTED TO THE FACULTY OF THE GRADUATE SCHOOL OF THE UNIVERSITY OF MINNESOTA BY Susan Kay Rathe IN PARTIAL FULFILLMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPHY David A. Largaespada October, 2013 © Susan Kay Rathe 2013 Acknowledgements Funding: The leukemia research was funded by The Leukemia & Lymphoma Society (grant 7019-04). The MMuFLR workflow was funded by The Children's Cancer Research Fund. University of Minnesota Resources: The BioMedical Genomics Center provided services for gene expression microarray, RNA sequencing, oligo preparation, and Sanger sequencing. The Minnesota Supercomputing Institute maintains the Galaxy Software, as well as provides data management services and training. The Masonic Cancer Center Bioinformatics Core provided guidance in the analysis of the RNA-seq data. The FDA Drug Screen was performed at the Institute for Therapeutics Discovery and Development. Colleagues: First and foremost, I would like to recognize Dr. David Largaespada for his mentorship and the opportunity to continue research he started while a postdoc in Dr. Neal Copeland’s lab. I would also like to thank the many members of the Largaespada lab who provided direct or indirect assistance to my research. Dr. Bin Yin continued Dr. Largaespada’s work on the BXH-2 AML cell lines by making drug resistant derivatives and provided training in cell culture and drug assay techniques. Dr. Won-Il Kim developed the TNM mouse model and provided training in mouse related experimental techniques. Miechaleen Diers did all of the tail vein injections for the AML transplants and assisted with necropsies.
    [Show full text]
  • Supplementary Information
    Supplementary Information This text file includes: Supplementary Methods Supplementary Figure 1-13, 15-30 Supplementary Table 1-8, 16, 20-21, 23, 25-37, 40-41 1 1. Samples, DNA extraction and genome sequencing 1.1 Ethical statements and sample storage The ethical statements of collecting and processing tissue samples for each species are listed as follows: Myotis myotis: All procedures were carried out in accordance with the ethical guidelines and permits (AREC-13-38-Teeling) delivered by the University College Dublin and the Préfet du Morbihan, awarded to Emma Teeling and Sébastien Puechmaille respectively. A single M. myotis individual was humanely sacrificed given that she had lethal injuries, and dissected. Rhinolophus ferrumequinum: All the procedures were conducted under the license (Natural England 2016-25216-SCI-SCI) issued to Gareth Jones. The individual bat died unexpectedly and suddenly during sampling and was dissected immediately. Pipistrellus kuhlii: The sampling procedure was carried out following all the applicable national guidelines for the care and use of animals. Sampling was done in accordance with all the relevant wildlife legislation and approved by the Ministry of Environment (Ministero della Tutela del Territorio e del Mare, Aut.Prot. N˚: 13040, 26/03/2014). Molossus molossus: All sampling methods were approved by the Ministerio de Ambiente de Panamá (SE/A-29-18) and by the Institutional Animal Care and Use Committee of the Smithsonian Tropical Research Institute (2017-0815-2020). Phyllostomus discolor: P. discolor bats originated from a breeding colony in the Department Biology II of the Ludwig-Maximilians-University in Munich. Approval to keep and breed the bats was issued by the Munich district veterinary office.
    [Show full text]
  • CREB3L1 Antibody (C-Term) Purified Rabbit Polyclonal Antibody (Pab) Catalog # Ap6589b
    10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 CREB3L1 Antibody (C-term) Purified Rabbit Polyclonal Antibody (Pab) Catalog # AP6589b Specification CREB3L1 Antibody (C-term) - Product Information Application WB, IHC-P, FC,E Primary Accession Q96BA8 Other Accession NP_443086 Reactivity Human, Mouse Host Rabbit Clonality Polyclonal Isotype Rabbit Ig Calculated MW 57005 Antigen Region 481-509 CREB3L1 Antibody (C-term) - Additional Information Western blot analysis of CREB3L1 Antibody Gene ID 90993 (C-term) (Cat. #AP6589b) in mouse stomach tissue lysates (35ug/lane). CREB3L1 (arrow) Other Names Cyclic AMP-responsive element-binding was detected using the purified Pab. protein 3-like protein 1, cAMP-responsive element-binding protein 3-like protein 1, Old astrocyte specifically-induced substance, OASIS, Processed cyclic AMP-responsive element-binding protein 3-like protein 1, CREB3L1, OASIS Target/Specificity This CREB3L1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 481-509 amino acids from the C-terminal region of human CREB3L1. Dilution WB~~1:8000 IHC-P~~1:50~100 FC~~1:10~50 Anti-CREB3L1 Antibody (C-term) at 1:8000 Format dilution + HepG2 whole cell lysate Purified polyclonal antibody supplied in PBS Lysates/proteins at 20 µg per lane. with 0.09% (W/V) sodium azide. This Secondary Goat Anti-Rabbit IgG, (H+L), antibody is prepared by Saturated Peroxidase conjugated at 1/10000 dilution. Ammonium Sulfate (SAS) precipitation Predicted band size : 57 kDa followed by dialysis against PBS. Blocking/Dilution buffer: 5% NFDM/TBST. Storage Maintain refrigerated at 2-8°C for up to 2 Page 1/3 10320 Camino Santa Fe, Suite G San Diego, CA 92121 Tel: 858.875.1900 Fax: 858.622.0609 weeks.
    [Show full text]
  • A Single-Cell Transcriptomic Landscape of Primate Arterial Aging
    ARTICLE https://doi.org/10.1038/s41467-020-15997-0 OPEN A single-cell transcriptomic landscape of primate arterial aging Weiqi Zhang 1,2,3,4,5,13, Shu Zhang6,7,13, Pengze Yan3,8,13, Jie Ren7,9,13, Moshi Song3,5,8, Jingyi Li2,3,8, Jinghui Lei4, Huize Pan2,3, Si Wang3,5,8, Xibo Ma3,10, Shuai Ma2,3,8, Hongyu Li2,3, Fei Sun2,3, Haifeng Wan3,5,11, ✉ ✉ ✉ Wei Li 3,5,11, Piu Chan4, Qi Zhou3,5,11, Guang-Hui Liu 2,3,4,5,8 , Fuchou Tang 6,7,9,12 & Jing Qu 3,5,11 Our understanding of how aging affects the cellular and molecular components of the vas- 1234567890():,; culature and contributes to cardiovascular diseases is still limited. Here we report a single-cell transcriptomic survey of aortas and coronary arteries in young and old cynomolgus monkeys. Our data define the molecular signatures of specialized arteries and identify eight markers discriminating aortic and coronary vasculatures. Gene network analyses characterize tran- scriptional landmarks that regulate vascular senility and position FOXO3A, a longevity- associated transcription factor, as a master regulator gene that is downregulated in six subtypes of monkey vascular cells during aging. Targeted inactivation of FOXO3A in human vascular endothelial cells recapitulates the major phenotypic defects observed in aged monkey arteries, verifying FOXO3A loss as a key driver for arterial endothelial aging. Our study provides a critical resource for understanding the principles underlying primate arterial aging and contributes important clues to future treatment of age-associated vascular disorders. 1 CAS Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, Beijing 100101, China.
    [Show full text]
  • S41467-020-18249-3.Pdf
    ARTICLE https://doi.org/10.1038/s41467-020-18249-3 OPEN Pharmacologically reversible zonation-dependent endothelial cell transcriptomic changes with neurodegenerative disease associations in the aged brain Lei Zhao1,2,17, Zhongqi Li 1,2,17, Joaquim S. L. Vong2,3,17, Xinyi Chen1,2, Hei-Ming Lai1,2,4,5,6, Leo Y. C. Yan1,2, Junzhe Huang1,2, Samuel K. H. Sy1,2,7, Xiaoyu Tian 8, Yu Huang 8, Ho Yin Edwin Chan5,9, Hon-Cheong So6,8, ✉ ✉ Wai-Lung Ng 10, Yamei Tang11, Wei-Jye Lin12,13, Vincent C. T. Mok1,5,6,14,15 &HoKo 1,2,4,5,6,8,14,16 1234567890():,; The molecular signatures of cells in the brain have been revealed in unprecedented detail, yet the ageing-associated genome-wide expression changes that may contribute to neurovas- cular dysfunction in neurodegenerative diseases remain elusive. Here, we report zonation- dependent transcriptomic changes in aged mouse brain endothelial cells (ECs), which pro- minently implicate altered immune/cytokine signaling in ECs of all vascular segments, and functional changes impacting the blood–brain barrier (BBB) and glucose/energy metabolism especially in capillary ECs (capECs). An overrepresentation of Alzheimer disease (AD) GWAS genes is evident among the human orthologs of the differentially expressed genes of aged capECs, while comparative analysis revealed a subset of concordantly downregulated, functionally important genes in human AD brains. Treatment with exenatide, a glucagon-like peptide-1 receptor agonist, strongly reverses aged mouse brain EC transcriptomic changes and BBB leakage, with associated attenuation of microglial priming. We thus revealed tran- scriptomic alterations underlying brain EC ageing that are complex yet pharmacologically reversible.
    [Show full text]
  • Identification of Cis-Regulatory Sequence
    Worsley-Hunt et al. Genome Medicine 2011, 3:65 http://genomemedicine.com/content/3/9/65 REVIEW Identication of cis-regulatory sequence variations in individual genome sequences Rebecca Worsley-Hunt1,2, Virginie Bernard1 and Wyeth W Wasserman1* Abstract for the appropriate patterning or magnitude of gene expression. Similarly, mutations can disrupt other sequence- Functional contributions of cis-regulatory sequence specific regulatory controls, such as elements regulating variations to human genetic disease are numerous. For RNA splicing or stability. Although much emphasis in the instance, disrupting variations in a HNF4A transcription age of exome sequencing has been placed on variation factor binding site upstream of the Factor IX gene within protein-encoding sequences, it is apparent that contributes causally to hemophilia B Leyden. Although regulatory sequence disruptions will become a key focus clinical genome sequence analysis currently focuses as full genome sequences become widely accessible for on the identication of protein-altering variation, the medical genetics research. impact of cis-regulatory mutations can be similarly e emerging collection of cis-regulatory variations strong. New technologies are now enabling genome that cause human disease or altered phenotype is grow- sequencing beyond exomes, revealing variation across ing [2-4]. Reports identify cis-acting, expression-altering the non-coding 98% of the genome responsible for mutations observed within introns, far upstream of developmental and physiological patterns of gene genes, at splicing sites or within microRNA target sites. activity. The capacity to identify causal regulatory For example, cis-regulatory mutations have roles in hemo- mutations is improving, but predicting functional philia, Gilbert’s syndrome, Bernard-Soulier syndrome, changes in regulatory DNA sequences remains a great irritable bowel syndrome, beta-thalassemia, cholesterol challenge.
    [Show full text]
  • Wild-Type Bone Marrow Cells ) Mice with −/− in C1q-Deficient (C1qa
    Reconstitution of the Complement Function in C1q-Deficient C1qa؊/؊) Mice with Wild-Type Bone Marrow Cells1) Franz Petry,2* Marina Botto,† Rafaela Holtappels,‡ Mark J. Walport,† and Michael Loos* Besides Ab-independent and Ab-dependent activation of the complement classical pathway in host defense, C1q plays a key role in the processing of immune complexes and in the clearance of apoptotic cells. In humans, C1q deficiency leads to systemic lupus erythematosus-like symptoms in over 90% of the cases, thus making this defect a strong disease susceptibility factor. Similarly, -C1q-deficient mice (C1qa؊/؊) develop systemic lupus erythematosus-like symptoms, such as autoantibodies and glomerulone phritis. We have previously provided evidence that C1q is produced by cells of the monocyte-macrophage lineage. In this study, .we have tested whether transplantation of bone marrow cells would be sufficient to reconstitute C1q levels in C1qa؊/؊ mice C1qa؊/؊ mice received a single graft of 107 bone marrow cells from wild-type (wt) donors after irradiation doses of 6, 7, 8, or 9 .Gy. Engraftment was monitored by a Y chromosome-specific PCR and a PCR that differentiated wt from C1qa؊/؊ genotype Serum levels of C1q Ag and C1 function increased rapidly in the recipient mice, and titers reached normal levels within 6 wk after bone marrow transplantation. In wt mice that received C1qa؊/؊ bone marrow, serum levels of C1q decreased constantly over time and became C1q deficient within 55 wk. These data clearly demonstrate that bone marrow-derived cells are the source of serum C1q and are competent to reconstitute normal C1q serum levels in C1q-deficient mice.
    [Show full text]
  • Transcriptome-Wide Profiling of Cerebral Cavernous Malformations
    www.nature.com/scientificreports OPEN Transcriptome-wide Profling of Cerebral Cavernous Malformations Patients Reveal Important Long noncoding RNA molecular signatures Santhilal Subhash 2,8, Norman Kalmbach3, Florian Wegner4, Susanne Petri4, Torsten Glomb5, Oliver Dittrich-Breiholz5, Caiquan Huang1, Kiran Kumar Bali6, Wolfram S. Kunz7, Amir Samii1, Helmut Bertalanfy1, Chandrasekhar Kanduri2* & Souvik Kar1,8* Cerebral cavernous malformations (CCMs) are low-fow vascular malformations in the brain associated with recurrent hemorrhage and seizures. The current treatment of CCMs relies solely on surgical intervention. Henceforth, alternative non-invasive therapies are urgently needed to help prevent subsequent hemorrhagic episodes. Long non-coding RNAs (lncRNAs) belong to the class of non-coding RNAs and are known to regulate gene transcription and involved in chromatin remodeling via various mechanism. Despite accumulating evidence demonstrating the role of lncRNAs in cerebrovascular disorders, their identifcation in CCMs pathology remains unknown. The objective of the current study was to identify lncRNAs associated with CCMs pathogenesis using patient cohorts having 10 CCM patients and 4 controls from brain. Executing next generation sequencing, we performed whole transcriptome sequencing (RNA-seq) analysis and identifed 1,967 lncRNAs and 4,928 protein coding genes (PCGs) to be diferentially expressed in CCMs patients. Among these, we selected top 6 diferentially expressed lncRNAs each having signifcant correlative expression with more than 100 diferentially expressed PCGs. The diferential expression status of the top lncRNAs, SMIM25 and LBX2-AS1 in CCMs was further confrmed by qRT-PCR analysis. Additionally, gene set enrichment analysis of correlated PCGs revealed critical pathways related to vascular signaling and important biological processes relevant to CCMs pathophysiology.
    [Show full text]
  • Association Between Chymase Gene Polymorphisms and Atrial Fibrillation
    Zhou et al. BMC Cardiovascular Disorders (2019) 19:321 https://doi.org/10.1186/s12872-019-01300-7 RESEARCH ARTICLE Open Access Association between chymase gene polymorphisms and atrial fibrillation in Chinese Han population Dongchen Zhou, Yuewei Chen, Jiaxin Wu, Jiabo Shen, Yushan Shang, Liangrong Zheng and Xudong Xie* Abstract Background: Chymase is the major angiotensin II (Ang II)-forming enzyme in cardiovascular tissue, with an important role in atrial remodeling. This study aimed to examine the association between chymase 1 gene (CMA1) polymorphisms and atrial fibrillation (AF) in a Chinese Han population. Methods: This case-control study enrolled 126 patients with lone AF and 120 age- and sex-matched healthy controls, all from a Chinese Han population. Five CMA1 polymorphisms were genotyped. Results: The CMA1 polymorphism rs1800875 (G-1903A) was associated with AF. The frequency of the GG genotype was significantly higher in AF patients compared with controls (p = 0.009). Haplotype analysis further demonstrated an increased risk of AF associated with the rs1800875-G haplotype (Hap8 TGTTG, odds ratio (OR) = 1.668, 95% CI 1.132–2.458, p = 0.009), and a decreased risk for the rs1800875-A haplotype (Hap5 TATTG, OR = 0.178, 95% CI 0.042– 0.749, p = 0.008). Conclusions: CMA1 polymorphisms may be associated with AF, and the rs1800875 GG genotype might be a susceptibility factor for AF in the Chinese Han population. Keywords: Atrial fibrillation, CMA1, Chymase, Single nucleotide polymorphism, Angiotensin II Background ‘lone AF’, occur in the absence of identifiable underlying Atrial fibrillation (AF) is the most common type of sus- cardiovascular or other comorbid diseases [4].
    [Show full text]